Analysts/Institutional Investor Meet/Con. Call Updates

AI summary - Q2FY27 consolidated revenue grew 42% y-y to INR 296 crore; EBITDA up 51% y-y to INR 45 crore - Battery chemicals revenue surged to INR 37 crore in Q2 from INR 5 crore last year; strong ramp-up expected in H2 FY27 - Organolithium capacity expansion approved, doubling to 600 MT/year with INR 45 crore capex; revenue potential INR 150-200 crore - Maiden QIP raised INR 600 crore, oversubscribed 6.5x, proceeds to deleverage and fund growth - Insurance claims total INR 316 crore secured/receivable; Dahej plant rebuild trial runs underway, commercial soon - FY28 net debt expected INR 1,300-1,500 crore; interest costs to decline with QIP and rating upgrade - Battery chemicals FY27 revenue guidance INR 250-300 crore; FY28 expected >INR 1,000 crore; strong US non-FEOC demand - Base business FY27 revenue expected INR 1,100 crore+; FY28 guidance raised to INR 1,200-1,300 crore - EBITDA margin guidance for standalone Neogen Chemicals 18-20%; Neogen Ionics expected EBITDA positive by FY28 - Capacity expansions planned with 15-18 month lead times; long-term growth to 8-9x current capacity over 7-8 years